Related Experiment Videos
Cognitive-behavioral therapy for social anxiety disorder
1Department of Psychology, Concordia University, Montreal, Quebec, Canada. radomsky@vax2.concordia.ca
The Psychiatric Clinics of North America
|November 29, 2001
Summary
Cognitive behavioral therapy (CBT) and pharmacotherapy offer effective treatments for Seasonal Affective Disorder (SAD). While pharmacotherapy may have slight short-term advantages, CBT provides lasting benefits and better cost-effectiveness for SAD patients.
Area of Science:
- Psychiatry
- Clinical Psychology
Background:
- Seasonal Affective Disorder (SAD) presents treatment challenges.
- Two primary evidence-based treatments exist: CBT and pharmacotherapy.
Purpose of the Study:
- To compare the efficacy and long-term outcomes of CBT versus pharmacotherapy for SAD.
- To assess the cost-benefit and maintenance of gains for SAD treatments.
Main Methods:
- Review of current research comparing CBT and pharmacotherapy for SAD.
- Analysis of acute outcomes, treatment gain maintenance, and cost-benefit ratios.
Main Results:
- Acute treatment outcomes are comparable, with a slight edge for pharmacotherapy.
- CBT demonstrates superior maintenance of treatment gains and a favorable cost-benefit ratio.
- Concerns exist regarding underutilization and limited access to experienced CBT therapists for SAD.
Conclusions:
- Both CBT and pharmacotherapy are viable options for SAD treatment.
- CBT offers significant advantages in long-term symptom management and cost-effectiveness.
- Improving access to experienced CBT providers is crucial for optimal SAD patient care.